Phase COVID-NA
Brain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders
- Study HIC#:2000023649
- Last Updated:02/22/2024
This study aims to investigate whether a parent-based treatment for childhood anxiety disorders engages child brain circuitry implicated in children's reliance on parents to reduce anxiety (R61), and whether change in child brain circuitry is associated with reduction in child anxiety (R33).
- Age6 years - 12 years
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Grace Hommel
- Phone Number: 1-203-737-4644
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Eligibility Criteria
Inclusion Criteria:
- Prepubertal
- Clinical diagnosis of primary anxiety disorder
- Must not have another mental illness more impairing than the most impairing anxiety disorder
- IQ of at least 80.
Exclusion Criteria:
- Neurological disorders (including seizures)
- Organic mental disorders, psychotic disorders, or pervasive developmental disorders
- High likelihood of hurting themselves or others
- Current psychosocial or psychopharmacological treatment
- History of neurological illness or head injury with loss of consciousness > 5 minutes
- Vision or physical disability that interferes with seeing stimuli presented briefly on computer screen and/or clicking a mouse button rapidly and repeatedly
- Contraindications for MRI scanning (e.g., metal implants, pacemakers, braces, claustrophobia, pregnancy, weight > 250 pounds).
